Macular degeneration (age-related) - pegaptanib and ranibizumab: appeal announcement
The Institute received 2 appeals from Pfizer and Derbyshire County PCT.
An appeal hearing was held on 30 June 2008. The Institute awaits the decision of the appeal panel.
This page was last updated: 30 March 2010